PMC:7402624 / 21268-21565 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T157","span":{"begin":33,"end":37},"obj":"Body_part"},{"id":"T158","span":{"begin":223,"end":227},"obj":"Body_part"},{"id":"T159","span":{"begin":260,"end":263},"obj":"Body_part"}],"attributes":[{"id":"A157","pred":"fma_id","subj":"T157","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A158","pred":"fma_id","subj":"T158","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A159","pred":"fma_id","subj":"T159","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"Together, these data highlight T cell activation in COVID-19 patients similar to what has been observed in other acute infections or vaccinations (37, 39, 40), but also identify patients with high, low, or essentially no T cell response based on KI67+ or CD38+HLA-DR+ compared to control subjects."}

{"project":"LitCovid-PubTator","denotations":[{"id":"710","span":{"begin":255,"end":259},"obj":"Gene"},{"id":"721","span":{"begin":61,"end":69},"obj":"Species"},{"id":"722","span":{"begin":178,"end":186},"obj":"Species"},{"id":"738","span":{"begin":52,"end":60},"obj":"Disease"},{"id":"739","span":{"begin":113,"end":129},"obj":"Disease"}],"attributes":[{"id":"A710","pred":"tao:has_database_id","subj":"710","obj":"Gene:952"},{"id":"A721","pred":"tao:has_database_id","subj":"721","obj":"Tax:9606"},{"id":"A722","pred":"tao:has_database_id","subj":"722","obj":"Tax:9606"},{"id":"A738","pred":"tao:has_database_id","subj":"738","obj":"MESH:C000657245"},{"id":"A739","pred":"tao:has_database_id","subj":"739","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Together, these data highlight T cell activation in COVID-19 patients similar to what has been observed in other acute infections or vaccinations (37, 39, 40), but also identify patients with high, low, or essentially no T cell response based on KI67+ or CD38+HLA-DR+ compared to control subjects."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T152","span":{"begin":52,"end":60},"obj":"Disease"},{"id":"T153","span":{"begin":119,"end":129},"obj":"Disease"}],"attributes":[{"id":"A152","pred":"mondo_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A153","pred":"mondo_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Together, these data highlight T cell activation in COVID-19 patients similar to what has been observed in other acute infections or vaccinations (37, 39, 40), but also identify patients with high, low, or essentially no T cell response based on KI67+ or CD38+HLA-DR+ compared to control subjects."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T380","span":{"begin":31,"end":37},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T381","span":{"begin":38,"end":48},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T382","span":{"begin":86,"end":89},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T383","span":{"begin":221,"end":227},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T384","span":{"begin":255,"end":259},"obj":"http://purl.obolibrary.org/obo/PR_000001408"}],"text":"Together, these data highlight T cell activation in COVID-19 patients similar to what has been observed in other acute infections or vaccinations (37, 39, 40), but also identify patients with high, low, or essentially no T cell response based on KI67+ or CD38+HLA-DR+ compared to control subjects."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T115","span":{"begin":264,"end":266},"obj":"Chemical"}],"attributes":[{"id":"A115","pred":"chebi_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"Together, these data highlight T cell activation in COVID-19 patients similar to what has been observed in other acute infections or vaccinations (37, 39, 40), but also identify patients with high, low, or essentially no T cell response based on KI67+ or CD38+HLA-DR+ compared to control subjects."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T52","span":{"begin":31,"end":48},"obj":"http://purl.obolibrary.org/obo/GO_0042110"},{"id":"T53","span":{"begin":33,"end":48},"obj":"http://purl.obolibrary.org/obo/GO_0001775"}],"text":"Together, these data highlight T cell activation in COVID-19 patients similar to what has been observed in other acute infections or vaccinations (37, 39, 40), but also identify patients with high, low, or essentially no T cell response based on KI67+ or CD38+HLA-DR+ compared to control subjects."}

{"project":"LitCovid-sentences","denotations":[{"id":"T133","span":{"begin":0,"end":297},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Together, these data highlight T cell activation in COVID-19 patients similar to what has been observed in other acute infections or vaccinations (37, 39, 40), but also identify patients with high, low, or essentially no T cell response based on KI67+ or CD38+HLA-DR+ compared to control subjects."}

{"project":"2_test","denotations":[{"id":"32669297-32320677-135105204","span":{"begin":151,"end":153},"obj":"32320677"},{"id":"32669297-28620653-135105205","span":{"begin":155,"end":157},"obj":"28620653"}],"text":"Together, these data highlight T cell activation in COVID-19 patients similar to what has been observed in other acute infections or vaccinations (37, 39, 40), but also identify patients with high, low, or essentially no T cell response based on KI67+ or CD38+HLA-DR+ compared to control subjects."}